UK Virus Update: Current Infections & Latest Information
As of early 2024, multiple respiratory and enteric viruses are co-circulating in the UK. Surveillance data (UKHSA, NHS) indicate:
Major Circulating Viruses
| Virus | Current Activity | Key Features | At-Risk Groups |
|---|---|---|---|
| COVID-19 (SARS-CoV-2) | Endemic; waves every 3-6 months. JN.1 variant dominant (winter 2023-24). | Fever, cough, fatigue, anosmia; long COVID risk. | Elderly, immunocompromised, unvaccinated, multimorbidity. |
| Influenza (Flu) | Seasonal (Oct-Mar). 2023-24: moderate A(H1N1)pdm09 + B/Victoria. | Abrupt fever, myalgia, headache, cough. | ≥65, <5, pregnant, chronic disease. |
| RSV | Seasonal (Oct-Mar). High 2023-24; pediatric hospitalizations. | Bronchiolitis in infants; cold-like in adults. | Infants <1, preterm, CHD, CLD, elderly. |
| Norovirus | Year-round; winter peaks. High 2023-24. | Vomiting, diarrhea, nausea; 12-48h incubation. | All ages; outbreaks in care homes, schools, hospitals. |
| Rhinovirus/Enterovirus | Year-round; fall/spring peaks. | Common cold; asthma exacerbations. | Children, asthmatics. |
| Adenovirus | Sporadic; can cause conjunctivitis, pneumonia. | Fever, pharyngitis, conjunctivitis, GI. | Children, military recruits, immunocompromised. |
Co-circulation & Co-infection
- Simultaneous infection with ≥2 viruses occurs (e.g., COVID+flu, RSV+rhinovirus).
- Co-infection may increase severity, especially in vulnerable populations.
- Multiplex PCR panels (respiratory pathogen panels) enable detection.
Public Health Guidance (UKHSA/NHS)
- Vaccination: COVID-19 autumn booster (eligible groups), annual flu vaccine, RSV vaccine (new: pregnant 28-36 wks, older adults 75-79), pneumococcal.
- Hygiene: Handwashing, respiratory etiquette, surface cleaning.
- Isolation: Stay home if febrile/unwell; 48h after norovirus symptoms cease.
- Masking: In healthcare, crowded indoor spaces, if symptomatic.
- Ventilation: Open windows, HEPA filters.
When to Seek Care
- Difficulty breathing, chest pain, confusion, inability to maintain fluids.
- High-risk individual with flu/COVID symptoms → early antiviral eligibility (oseltamivir, nirmatrelvir/ritonavir).
- Infant <3 months with fever ≥38°C.
Check UKHSA surveillance reports for weekly updates.
Viral Infections - Related Articles
- CMV Infection: Symptoms, Causes & Treatment
- Dorsal Blood Vessel in Earthworms: Circulatory Function
- Salmonella: Understanding Risks, Prevention, and Transmission
- Understanding Viruses: Why Harmless Viruses Are Impossible
- Understanding Influenza (Flu): Types, Symptoms & Treatment
- Ross River Virus in Australia: Epidemiology, Symptoms, and Prevention
- Viral Gastroenteritis: Causes, Symptoms & Treatment
